Xencor (XNCR) Common Equity (2013 - 2026)
Xencor's (XNCR) quarterly Common Equity came in at $515.6 million in Q1 2026, down 19.42% year-on-year from $639.9 million in Q1 2025, and down 18.87% on a QoQ basis from $635.6 million in Q4 2025.
Xencor (XNCR) Common Equity (2013 - 2026) Analysis & Trends
Xencor (XNCR) has 14 years of Common Equity data on file, last reported at $515.6 million in Q1 2026.
- On a quarterly basis, Common Equity fell 19.42% year-over-year to $515.6 million in Q1 2026; TTM through Mar 2026 was $515.6 million, a 19.42% decrease from a year earlier, with the FY2025 full-year figure at $635.6 million, down 5.7% from the prior year.
- Common Equity for Q1 2026 stood at $515.6 million, down from $635.6 million in the prior quarter.
- Over the last five years, Common Equity for XNCR reached as high as $763.0 million in Q1 2022 and fell as low as $515.6 million in Q1 2026.
- Historically, Common Equity has averaged $659.7 million across 5 years, with a median of $669.0 million in 2023.
- Across the five-year window, Common Equity soared 30.74% in 2022 and fell 19.42% in 2026, its largest moves.
- Year by year, Common Equity stood at $727.5 million in 2022, then slipped by 8.99% to $662.1 million in 2023, then advanced by 1.8% to $674.0 million in 2024, then decreased by 5.7% to $635.6 million in 2025, then declined by 18.87% to $515.6 million in 2026.
- Per Business Quant data, the three most recent Common Equity figures were $515.6 million in Q1 2026, $635.6 million in Q4 2025, and $625.3 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 251.12 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | -98.34 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 4.76 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 32.36 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 19.36 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 31.42 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 795.79 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 1.50 Bn |
| 10 | Xencor | 1.47 Bn | 1.09 Bn | - | 515.63 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 515.63 Mn |
| Dec 31, 2025 | 635.59 Mn |
| Sep 30, 2025 | 625.32 Mn |
| Jun 30, 2025 | 620.35 Mn |
| Mar 31, 2025 | 639.87 Mn |
| Dec 31, 2024 | 674.03 Mn |
| Sep 30, 2024 | 705.93 Mn |
| Jun 30, 2024 | 548.71 Mn |
| Mar 31, 2024 | 599.73 Mn |
| Dec 31, 2023 | 662.09 Mn |
| Sep 30, 2023 | 669.01 Mn |
| Jun 30, 2023 | 678.88 Mn |
| Mar 31, 2023 | 683.58 Mn |
| Dec 31, 2022 | 727.50 Mn |
| Sep 30, 2022 | 722.70 Mn |
| Jun 30, 2022 | 742.34 Mn |
| Mar 31, 2022 | 763.02 Mn |
| Dec 31, 2021 | 733.50 Mn |
| Sep 30, 2021 | 618.86 Mn |
| Jun 30, 2021 | 646.94 Mn |